45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
3,280
Insurances with rates
51
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| PX-8910000008 | HC Idecabtagene Vicleucel Car 50ml (Abecma) | $2,884,058 | $1,874,637 | — | — | 113 |
| RX-4081151288 | TAGRAXOFUSP-ERZS DILUTION 100 MCG/ML IV SOLN | $1,238,387 | $804,951 | — | — | 118 |
| RX-21672 | CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT | $162,708 | $105,760 | — | — | 46 |
| PX-2780001167 | HC Remede System 1600 | $158,125 | $102,781 | — | — | 38 |
| PX-8130000000 | HC Cadaver Donor Sac-Pancreas | $121,000 | $78,650 | — | — | 37 |
| PX-4803327600 | HC Insertion Phrenic Nerve Stimulator System | $112,501 | $73,126 | — | — | 93 |
| RX-12519 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $108,457 | $70,497 | — | — | 118 |
| PX-3613324900 | HC Ins/Repl Defibrillator W/Sgl Lead | $108,000 | $70,200 | — | — | 118 |
| SUP-9600CT29A | VALVE CERTITUDE 29MM (9600CT29A 153923) | $89,375 | $58,094 | — | — | 30 |
| PX-4800915000 | HC Insj Perm Ccm-D Sys Pg&Dual Transvns Eltrds/Lds | $80,154 | $52,100 | — | — | 93 |
| PX-4800408000 | HC Insj/Rplc Cardiac Modulj Sys | $80,154 | $52,100 | — | — | 106 |
| PX-4816465600 | HC Revision/Rplcmt Bat Modulation System Pg Only | $78,815 | $51,230 | — | — | 101 |
| PX-2780000625 | HC Therasphere Yttrium-90 | $66,719 | $43,367 | — | — | 104 |
| RX-408115238776 | TARLATAMAB-DLLE 10 MG IV SOLR | $59,513 | $38,684 | — | — | 117 |
| RX-111348 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $50,732 | $32,975 | — | — | 118 |
| SUP-G125 | ICD MOMENTUM CRT-D DF1 (G125 148800) | $46,888 | $30,477 | — | — | 36 |
| PX-3613727700 | HC Rvsc Evsc Fpvt St Athr Cpx 1st Vsl | $46,822 | $30,434 | — | — | 84 |
| PX-3613727400 | HC Revsc Evasc Fpvt Athrc Uni Cplx Les Ea Addl Vsl | $46,822 | $30,434 | — | — | 33 |
| PX-3613729300 | HC Revsc Evasc Tpvt St Athrc Uni Sf Les Ea Addl Vsl | $46,822 | $30,434 | — | — | 33 |
| PX-3613728500 | HC Revsc Evasc Tpvt St Sf Ea Add Vsl | $46,822 | $30,434 | — | — | 33 |
| PX-3613727200 | HC Revsc Evasc Fpvt Athrc Uni Sf Les Ea Addl Vsl | $46,822 | $30,434 | — | — | 33 |
| PX-3613727500 | HC Rvsc Evsc Fpvt St Athrc Sf 1st Vsl | $46,822 | $30,434 | — | — | 84 |
| PX-3613728900 | HC Revsc Evsc Tpvt Athrc Sf Ea Add Vsl | $46,822 | $30,434 | — | — | 33 |
| RX-235651 | TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION | $46,149 | $29,997 | — | — | 103 |
| PX-4800823000 | HC Tcat Ins 1chmbr Ldls Pm Ra | $45,199 | $29,379 | — | — | 117 |
| PX-3610979700 | HC Vascular Embol/Occl W/Press Cath | $44,892 | $29,180 | — | — | 106 |
| PX-4810981000 | HC Tcat Impl Wrls Ivc Snr | $44,892 | $29,180 | — | — | 93 |
| PX-4810960600 | HC Perc D-E Cor Revasc W Ami Sgl | $44,654 | $29,025 | — | — | 59 |
| RX-233716 | ANTIHEMOPHIL RFVIII FC-VWF-XTEN,BDD-EHTL 2,000 (+/-) UNIT IV SOLUTION | $43,849 | $28,502 | — | — | 105 |
| RX-212239 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $42,295 | $27,492 | — | — | 98 |
| RX-230966 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $41,978 | $27,286 | — | — | 118 |
| RX-212758 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $39,274 | $25,528 | — | — | 118 |
| PX-3610238000 | HC Trluml Perip Athrc Iliac Art | $38,738 | $25,180 | — | — | 106 |
| PX-3613722500 | HC Fem/Popl Revas W/Ather | $37,435 | $24,333 | — | — | 42 |
| SUP-G53439 | GRAF ENDO TX2 2P-42-135 (G53439 C27429) | $36,584 | $23,780 | — | — | 30 |
| RX-108955 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $35,577 | $23,125 | — | — | 118 |
| PX-3200627000 | HC Perq Njx Algc Cell &/Prdct Uni/Bi Fluor Lmbr 1st | $35,146 | $22,845 | — | — | 95 |
| RX-40830523 | ALTEPLASE 0.9 MG/KG IV (NTE 90 MG) FOR STROKE | $33,899 | $22,034 | — | — | 118 |
| PX-4810659000 | HC Tcat Intra-C Nfs Supersat O2 | $33,816 | $21,980 | — | — | 53 |
| RX-214622 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $32,920 | $21,398 | — | — | 95 |
| RX-408031244 | TENECTEPLASE 25 MG/5 ML INTRAVENOUS SOLUTION | $32,920 | $21,398 | — | — | 95 |
| PX-4025172100 | HC Ins Trurl Ablt Trnsdc Thr US | $32,482 | $21,113 | — | — | 79 |
| PX-3615588200 | HC Ablt Trurl Prst8 Tis Trnsdcr | $32,481 | $21,113 | — | — | 90 |
| SUP-D232 | ICD VIGILANT EL V DF4 (D232 146405) | $31,006 | $20,154 | — | — | 36 |
| RX-235680 | ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION | $30,693 | $19,951 | — | — | 103 |
| SUP-RMT231414 | EXCLUDER C3 23X14X14 (RMT231414 A57781) | $30,235 | $19,653 | — | — | 30 |
| RX-15996 | METHADONE 10 MG/ML ORAL CONCENTRATE | $29,500 | $19,175 | — | — | 30 |
| PX-3613729800 | HC Revsc Evasc Imvt Angiop Uni Cplx Les 1st Vsl | $29,486 | $19,166 | — | — | 82 |
| PX-3613729700 | HC Revsc Evasc Imvt Angiop Uni Sf Les Ea Addl Vsl | $29,486 | $19,166 | — | — | 33 |
| PX-3613725800 | HC Revsc Evasc Ivt Stent Sf 1st Vsl | $29,486 | $19,166 | — | — | 90 |
Showing top 50 of 3,280 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.